Haemonetics | HAE - Cost Of Sales


Haemonetics reported $136.58M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Avanos Medical USD 88M 6.9M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Cerus USD 23.42M 3.61M Dec/2024
Cooper Companies USD 393.8M 17M Mar/2026
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Globus Medical USD 263.59M 26.88M Mar/2026
Haemonetics USD 136.58M 4.01M Dec/2025
ICU Medical USD 337.72M 1.61M Dec/2025
Intuitive Surgical USD 940.3M 21.6M Mar/2026
Masimo USD 152.8M 12.4M Mar/2026
Medtronic USD 3.8B 195M Mar/2026
Merit Medical Systems USD 197.08M 1.5M Mar/2026
Neogen USD 112.2M 5.81M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD -79.5M 528.3M Mar/2026
ResMed USD 551.67M 4.17M Mar/2026
STAAR Surgical USD 24.66M 10.6M Mar/2026
Steris USD 891.3M 50.6M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Surmodics USD 9.49M 23.54M Jun/2025
Teleflex USD 240.84M 20.7M Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
US Physical Therapy USD 163.6M 2.74M Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026